| Authors: |
Swoboda R; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland. ryszard.swoboda@gliwice.nio.gov.pl., Labopin M; EBMT Unit, Saint-Antoine Hospital, AP-HP, INSERM UMRs, Sorbonne University, Paris, France., Kröger N; University Hospital Eppendorf, Hamburg, Germany., Stelljes M; University of Muenster, Muenster, Germany., Schroeder T; University Hospital, Essen, Germany., Dreger P; University of Heidelberg, Heidelberg, Germany., Bug G; Goethe-Universitaet, Frankfurt Main, Germany., McDonald A; ALBERTS CELLULAR THERAPY, Pretoria, South Africa., Özçelik T; Demiroglu Bilim University Istanbul Florence Nightingale Hospital, Istanbul, Turkey., Rovira M; BMT Unit, Haematology Department, Institute of Haematology and Oncology, IDIBAPS, Hospital clinic, University of Barcelona, Barcelona, Spain., Blau IW; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany., Kunadt D; University Hospital Dresden, TU Dresden, Dresden, Germany., Peffault de Latour R; BMT Unit, Saint-Louis Hospital, Paris, France., Rabitsch W; BMT-Unit, Internal Medicine 1, Medical University of Vienna, Vienna, Austria., Eder M; Hannover Medical School, Hannover, Germany., Rubio MT; CHRU NANCY, Vandoeuvre les Nancy, Nancy, France., Spyridonidis A; University of Patras, Patras, Greece., Peric Z; University of Zagreb and University Hospital Centre Zagreb, Zagreb, Croatia., Giebel S; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Mohty M; EBMT Unit, Saint-Antoine Hospital, AP-HP, INSERM UMRs, Sorbonne University, Paris, France., Ciceri F; IRCCS Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy. |
